Search | Page 12 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clinical results with the DNA hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in patients with myelodysplastic syndromes: an update

    ... been shown to be active in numerous studies including International Prognostic Scoring System (IPSS) intermediate-1 to high risk patients, in ...

    Research Article last updated 11/05/2012 - 9:34am.

  2. TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression.

    ... marrow (BM) samples from 55 consecutive patients with International Prognostic Scoring System low risk (n = 32) or intermediate-1 risk (n = 23) ...

    Research Article last updated 10/11/2011 - 5:58pm.

  3. Practical use of azacitidine in higher-risk myelodysplastic syndromes: an expert panel opinion.

    ... over conventional care regimens in patients with International Prognostic Scoring System (IPSS) intermediate-2 (Int-2) and high-risk ...

    Research Article last updated 10/11/2011 - 5:58pm.

  4. High-risk myelodysplastic syndromes: chemotherapy, transplantation, and beyond.

    ... with considerable nonrelapse mortality and morbidity. The International Prognostic Scoring System, despite its confines, remains a widely used tool ...

    Research Article last updated 10/11/2011 - 5:58pm.

  5. Enhancing survival outcomes in the management of patients with higher-risk myelodysplastic syndromes.

    ... intermediate-2 or high-risk disease as classified by the International Prognostic Scoring System (IPSS). These patients represent 29% of the MDS ...

    Research Article last updated 10/11/2011 - 5:58pm.

  6. Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Societe Francaise de Greffe de Moelle et de Therapie-Cellulaire and the Groupe-Francophone des Myelodysplasies

    ... had intermediate-2 or high-risk MDS according to the International Prognostic Scoring System (IPSS). Progression to more advanced disease ...

    Research Article last updated 11/05/2012 - 8:57am.

  7. Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia.

    ... World Health Organization (WHO) classification and the International Prognostic Scoring System (IPSS). Significant differences in methylation ...

    Research Article last updated 04/26/2012 - 8:35am.

  8. Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes.

    ... between chelated and nonchelated patients in terms of International Prognostic Scoring System (IPSS), French-American-British (FAB), and/or ...

    Research Article last updated 10/11/2011 - 5:58pm.

  9. New MDS Prognostic Scoring System May Lead to More Effective Treatment

    ... New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge ... The International Prognostic Scoring System (IPSS) is used by doctors to evaluate the ...

    Research Review last updated 05/02/2016 - 9:33am.

  10. Study to Evaluate Imetelstat (JNJ-63935937) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02598661 ...

    Clinical Trial last updated 04/20/2016 - 3:39pm.